Evaluation of a targeted prodrug strategy to enhance oral absorption of poorly water-soluble compounds

被引:29
作者
Chan, OH [1 ]
Schmid, HL
Stilgenbauer, LA
Howson, W
Horwell, DC
Stewart, BH
机构
[1] Parke Davis Pharmaceut Res, Pharmacokinet & Drug Metab Dept, Ann Arbor, MI 48105 USA
[2] Parke Davis Neurosci Res Ctr, Dept Chem, Cambridge CB2 2QB, England
关键词
absorption; bioavailability; neurokinin; solubility; tachykinin; targeted prodrug;
D O I
10.1023/A:1011969808907
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. The purpose of this research was to examine a targeted prodrug strategy to increase the absorption of a poorly water-soluble lipophilic compound. Methods. Three water-soluble prodrugs of Cam-4451 were synthesized. The amino acid (Cam-4562, Cam-4580) or phosphate (Cam-5223) ester prodrugs introduced moieties ionized at physiological pn and targeted intestinal brush-border membrane enzymes fur reconversion to the parent. Selectivity for reconversion of the three prodrugs was examined in rat intestinal perfusate and brush-border membrane suspensions. Bioavailability of Cam-4451 in rats was evaluated after administering orally as the parent or as prodrugs in a cosolvent vehicle or in methylcellulose. Results. Cam-5223 was highly selective for reconversion at the brush-border, but was rapidly reconverted in intestinal perfusate. Cam-4562 was not as selective but was more stable in the perfusate, whereas Cam-4580 was neither selective nor stable. Oral bioavailability of Cam-4451 was 14% after dosing as the parent in the cosolvent vehicle, 39% and 46%, respectively, as Cam-4562 and Cam-5223. Oral bioavailability was only 3.6% when the parent was dosed in methylcellulose, whereas the bioavailability was 7-fold higher when dosed as the phosphate predrug. Conclusions. Water-soluble prodrugs that target brush-border membrane enzymes for reconversion can be useful in improving drug oral bioavailability.
引用
收藏
页码:1012 / 1018
页数:7
相关论文
共 15 条
[1]   IMPROVING INTESTINAL-ABSORPTION OF WATER-INSOLUBLE COMPOUNDS - A MEMBRANE METABOLISM STRATEGY [J].
AMIDON, GL ;
LEESMAN, GD ;
ELLIOTT, RL .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1980, 69 (12) :1363-1368
[2]   ANALYSIS OF MODELS FOR DETERMINING INTESTINAL WALL PERMEABILITIES [J].
AMIDON, GL ;
KOU, J ;
ELLIOTT, RL ;
LIGHTFOOT, EN .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1980, 69 (12) :1369-1373
[3]  
AMIDON GL, 1981, TECHNIQUES SOLUBILIZ, P183
[4]   INTERSPECIES VARIATION IN LIVER WEIGHT, HEPATIC BLOOD-FLOW, AND ANTIPYRINE INTRINSIC CLEARANCE - EXTRAPOLATION OF DATA TO BENZODIAZEPINES AND PHENYTOIN [J].
BOXENBAUM, H .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1980, 8 (02) :165-176
[5]   Absorption of Cam-2445, an NK1 neurokinin receptor antagonist: In vivo, in situ, and in vitro evaluations [J].
Chan, OH ;
Schmidt, HL ;
Kuo, BS ;
Wright, DS ;
Howson, W ;
Stewart, BH .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1996, 85 (03) :253-257
[6]   PHYSIOLOGICAL-PARAMETERS IN LABORATORY-ANIMALS AND HUMANS [J].
DAVIES, B ;
MORRIS, T .
PHARMACEUTICAL RESEARCH, 1993, 10 (07) :1093-1095
[7]   ORAL ABSORPTION OF 21-CORTICOSTEROID ESTERS - A FUNCTION OF AQUEOUS STABILITY AND INTESTINAL ENZYME-ACTIVITY AND DISTRIBUTION [J].
FLEISHER, D ;
JOHNSON, KC ;
STEWART, BH ;
AMIDON, GL .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1986, 75 (10) :934-939
[8]   Improved oral drug delivery: Solubility limitations overcome by the use of prodrugs [J].
Fleisher, D ;
Bong, R ;
Stewart, BH .
ADVANCED DRUG DELIVERY REVIEWS, 1996, 19 (02) :115-130
[9]   Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings [J].
Lipinski, CA ;
Lombardo, F ;
Dominy, BW ;
Feeney, PJ .
ADVANCED DRUG DELIVERY REVIEWS, 1997, 23 (1-3) :3-25
[10]  
Stein W. D., 1967, MOVEMENT MOL CELL ME, P65